Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “100 Stage I Patients”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Early research (Phase 1)Ended earlyNCT04252417
What this trial is testing

HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects

Who this might be right for
Healthy VolunteersHepatic Impairment of Moderate Child Pugh Category
MedDay Pharmaceuticals SA 15
Testing effectiveness (Phase 2)Study completedNCT00019214
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00657774
What this trial is testing

A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands

Who this might be right for
Asthma
SkyePharma AG 160
Early research (Phase 1)Ended earlyNCT01207973
What this trial is testing

Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee

Who this might be right for
Osteoarthritis
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT04849026
What this trial is testing

Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18

Who this might be right for
Schizophrenia
Whanin Pharmaceutical Company 33
Not applicableNot Yet RecruitingNCT07376096
What this trial is testing

Liquid Biopsy in Germ Cell Tumors

Who this might be right for
100 Stage I Patients100 Metastatic Patients
Medical University of Graz 200
Early research (Phase 1)Study completedNCT01707342
What this trial is testing

Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients

Who this might be right for
Healthy Male Participants
Janssen R&D Ireland 6
Early research (Phase 1)Ended earlyNCT04252430
What this trial is testing

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

Who this might be right for
Healthy VolunteersImpaired Renal Function
MedDay Pharmaceuticals SA 24
Early research (Phase 1)Looking for participantsNCT04866641
What this trial is testing

Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Taivex Therapeutics Corporation 40
Testing effectiveness (Phase 2)UnknownNCT00010309
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT00633269
What this trial is testing

Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours

Who this might be right for
Neoplasm Metastasis
AstraZeneca 6
Early research (Phase 1)Study completedNCT02430311
What this trial is testing

The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.

Who this might be right for
Advanced Solid Tumours
AstraZeneca 36
Early research (Phase 1)Active Not RecruitingNCT05396859
What this trial is testing

Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
OHSU Knight Cancer Institute 13
Early research (Phase 1)Study completedNCT00008099
What this trial is testing

Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Pittsburgh 25